LongCovid
A new prospective cohort study published by Nature Medicine (Nature Portfolio) on Long COVID. From more than 1,800 adults hospitalized with Covid-19, the authors identified two distinct biomarker profiles…
Ziyad Al-Aly, chief of research and development at the Veterans Affairs St. Louis Health Care System and a clinical epidemiologist at Washington University in St. Louis, did recently a…
New publication in the Lancet. “The COVID-19 pandemic exposed crucial fault lines in society both within and between different societies. Over the past 3 years, inequity has been…
This study led by the Imperial College London was recently published by Nature Communications. In the study, SARS-CoV-2 humoral and cellular immunity in 86 healthcare workers with laboratory…
By tracking Covid-19 patients, doctors in Europe are in search of treatments for a lingering sickness that is both debilitating and puzzling. Horizon, the EU Research & Innovation…
In May 2023, the World Health Organisation declared COVID-19 as no longer a public health emergency of international concern (PHEIC), however, a recent rise in cases and the…
The San Diego Union-Tribune has recently published an editorial on the new Long COVID study by Dr. Ziyad Al-Alyand (Nature Medicine Journal). “The perception that the pandemic is…
In a study recently published study, researchers from the University of New South Wales and St. Vincent’s Hospital have identified a key pathway, involved in inflammation, which appears…
Do not miss this interesting article published by Fortune based on a paper published recently in Nature Medicine. The article also includes an interview with the senior author of that paper,…
In this prospective observational cohort study carried out by Charité – Universitätsmedizin Berlin, symptom severity and various biomarkers were evaluated in 106 patients with Post-COVID-19 syndrome (PCS) with moderate to…